Get started with ClearStrand-ASD

Proceed with requesting ClearStrand-ASD now or explore your other options.

ClearStrand-ASD

  • Autism biomarker diagnostic aid
  • Rule-out accuracy: 95% 
  • Prescription only
  • Ages 1-48 months
  • Results within weeks
  • Telehealth visit to review results with ordering provider
$749 $499
Introductory price valid until 6/30/25

Request ClearStrand-ASD online now through an independent telehealth provider.

Request Now

ClearStrand-ASD biomarker test + Virtual Diagnostic Evaluation

  • ClearStrand-ASD
  • Virtual autism evaluation performed by a specialist
  • Evaluation performed as early as 16 months
  • Full diagnostic report provided
Coming soon

Get a full autism evaluation from the comfort of your home with one of our virtual diagnostic evaluation partners.

Coming soon
Name

Please enter your full name.

This test is intended for children between 1 and 48 months of age.

This is an informational conversation about our test and clinical research. No personal medical advice will be provided. Please consult your healthcare provider for clinical guidance.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Page contents

Important information

ClearStrand-ASD is a biochemical test intended to help health care providers rule out autism spectrum disorder (ASD) when it is a concern in children aged 1 month up to 4 years (48 months) of age. It detects a biomarker associated with autism using a strand of hair. ClearStrand-ASD must be ordered by a licensed health care provider. Rx only. ClearStrand-ASD results can be negative or non-negative.

A child with a negative result is unlikely to be on the autism spectrum. A child with a non-negative result may need further autism diagnostic evaluation. ClearStrand-ASD is not a standalone diagnostic test. Health care providers should consider the test result in the context of other factors relevant to their clinical decision making. ClearStrand-ASD analyzes a strand of hair to map the dynamic patterns of an individual's unique biological response to environmental exposures over time at a molecular level and uses an algorithm to assess the likelihood of autism from the patterns. It is not a genetic test. 

The test is performed by the LinusBio CLIA-certified laboratory (CLIA #31d2307499) and has not been cleared or approved by the US Food and Drug Administration (FDA).